Gillen, Jessica
Richardson, Debra
Moore, Kathleen
Article History
First Online: 26 February 2019
Compliance with Ethical Standards
:
: Jessica Gillen declares that she has no conflict of interest.Debra Richardson has received compensation from Genentech and Ipsen for participation on advisory boards, and has served on steering committees for and received travel grants from Tesaro and Karyopharm Therapeutics.Kathleen Moore has received research funding for investigator-initiated trials from ImmunoGen, Genentech/Roche, PTC Therapeutics, and Eli Lilly; has received compensation for participation on advisory boards from Clovis, AstraZeneca, Tesaro, ImmunoGen, Genentech/Roche, VBL Therapeutics, Janssen, Aravive, OncoMed, Samumed, and Merck; has received compensation for sales force training from Pfizer; and served as an unbranded speaker for AstraZeneca for DNA damage response.
: This article does not contain any studies with human or animal subjects performed by any of the authors.